(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ARARIS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ARARIS

ST13

US500000079418078

Classe

1, 5, 35, 42

Pedido

79418078

Registro

8081813

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

30/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 35, 42

Data de depósito

31/07/2024

Data de registro

30/12/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/12/2025

Última transação

30/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

CH

Examinador

O'BRIEN, JENNIFER LYNN

Unidade examinadora

N30

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Araris Biotech AG

Representantes

Catherine F Hoffman Baker, Donelson, Bearman, Caldwell & Berkowitz, PC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 35Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science namely, chemicals for use in industry and science, biochemical preparations for scientific purposes, Biological preparations for use in industry and science, assays and reagents for use in genetic research; bioactive reagents and compounds namely, diagnostic reagents and preparations, except for medical or veterinary use; peptide substrates for scientific purposes; peptide derivatives in the nature of peptide substrates for scientific purposes, proteins in raw material form for scientific and medical research, glycans being chemicals for use in industry and science, nucleotides for scientific and medical research use, lipids used in the manufacture of cosmetics, beverages, food products and food supplements, monoclonal antiobodies for scientific purposes, antibody-active principle conjugates in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or vetinary purposes, antibody fragments in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, antibody derivatives in the nature of antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes, nucleic acids other than for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for scientific use, viral vectors for research purposes; chemical, biochemical, biological, biotechnological and molecular genetic preparations in the nature of assays and reagents for use in genetic research for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides for in vitro research use and industrial proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides for in vetro research use, peptide derivatives in the nature of peptide substrates for scientific purposes and industrial proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.

Classe 5

Pharmaceutical products namely, pharmaceutical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; medical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely synthetic peptides for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases, diagnostic preparations for medical or veterinary purposes in the nature of peptide derivatives being substates, proteins arrays for medical diagnosis purposes, antibodies for medical purposes, active antibody conjugates being antibodies for medical purposes, antibody fragments being antibodies for medical purposes, antibody derivatives being antibodies for medical purposes, nucleic acids for medical or veterinary purposes, DNA being diagnostic preparations for in vitro testing for medical use, viral vector vaccines; pharmaceutical products and substances being pharmaceutical preparations for the treatment of diseases and preparations for medical treatments of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases

Classe 35

Providing business information with respect to business contacts for research projects.

Classe 42

Scientific and technological services as well as research work and design services relating thereto, namely, scientific research services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; Scientific laboratory services of a biochemical or pharmaceutical laboratory ; industrial analysis and research services in the field of pharmaceutical science ; development and research experimentation of medicines; Medical and scientific research, namely conducting preclinical and clinical trials for others; laboratory services for the benefit of third parties, namely,Medical laboratory services; scientific research advisory services in the biochemical, biological and molecular genetic fields; scientific research advice for the pharmaceutical industry sector; scientific research analysis services for medical and pharmaceutical research services in connection with the treatment of individuals; provision of scientific research information and results.

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

30/07/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/07/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

26/07/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/07/2026

FIMP

FINAL DISPOSITION PROCESSED

11/07/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/03/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

30/12/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

30/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/11/2025

PUBO

PUBLISHED FOR OPPOSITION

11/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/11/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/10/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

14/10/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/10/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

14/10/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/10/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/09/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/09/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/09/2025

RFNT

REFUSAL PROCESSED BY IB

04/05/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/04/2025

RFRR

REFUSAL PROCESSED BY MPU

15/04/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/03/2025

CNRT

NON-FINAL ACTION WRITTEN

07/03/2025

DOCK

ASSIGNED TO EXAMINER

01/03/2025

MAFR

APPLICATION FILING RECEIPT MAILED

28/02/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/02/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/02/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ARARIS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.